Dumasig, Rile Aero .

HRN: 23-31-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/26/2026
04/02/2026
ORAL
7ml
TID
T/C Intestinal Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: